Company / Operating Cash Flow per Share
Arcutis Biotherapeutics, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.05
FY2025
5-year range
-$4.68 / -$0.05
FY2021-FY2025
Trend
+95.9%
vs FY2024
Sector context
#77 of 212
Health Care
What the data says
At $-0.05, Arcutis Biotherapeutics, Inc.'s operating cash flow per share ranks #77 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-4.68 in FY2022 to $-0.05 in FY2025.
Based on SEC 10-K filings.
-0.05 in FY2025.
Improved from $-3.56 to $-0.05 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 212 in Health CareTop 36% of 212This company -$0.05 Sector average $5.28
▼
-100.9% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 95.9% year-over-year.
- Ranks #77 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.05 | +95.9% |
| FY2024 | -$1.16 | +67.5% |
| FY2023 | -$3.56 | +23.9% |
| FY2022 | -$4.68 | -32.5% |
| FY2021 | -$3.53 | -11.5% |
| FY2020 | -$3.17 | +86.4% |
| FY2019 | -$23.24 | -104.5% |
| FY2018 | -$11.36 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026